Resume-aware faculty matching

Find professors who actually fit you

Review faculty evidence in public, then use the workspace to turn your background into a shortlist, outreach, and meeting prep.

Profile-awarePaper evidenceSix agents

Teruo Okano

· Professor

University of Utah · Department of Pharmaceutics & Pharmaceutical Chemistry

Active 1960–2025

h-index160
Citations97.2k
Papers1.5k76 last 5y
Funding

Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.

See your match with Teruo Okano — sign in to PhdFit.Sign in

About

Teruo Okano is a faculty member at the College of Pharmacy, specifically associated with the Department of Molecular Pharmaceutics. His research focus involves molecular pharmaceutics, contributing to the development and understanding of pharmaceutical sciences. The page indicates his role within the department and his contact information, but does not provide detailed information about his background, specific research contributions, or key achievements.

Research topics

  • Biology
  • Medicine
  • Pathology
  • Cell biology
  • Anatomy
  • Chemistry
  • Biomedical engineering
  • Surgery
  • Bioinformatics
  • Immunology

Selected publications

  • 3D cell sheet structure augments mesenchymal stem cell cytokine production

    Scientific Reports · 2021 · 87 citations

    Senior authorCorresponding

    Mesenchymal stem cells (MSCs) secrete paracrine factors that play crucial roles during tissue regeneration. An increasing body of evidence suggests that this paracrine function is enhanced by MSC cultivation in three-dimensional (3D) tissue-like microenvironments. Toward this end, this study explored scaffold-free cell sheet technology as a new 3D platform. MSCs cultivated on temperature-responsive culture dishes to a confluent 2D monolayer were harvested by temperature reduction from 37 to 20 °…

  • Trends in Articular Cartilage Tissue Engineering: 3D Mesenchymal Stem Cell Sheets as Candidates for Engineered Hyaline-Like Cartilage

    Cells · 2021 · 55 citations

    Senior authorCorresponding

    Articular cartilage defects represent an inciting factor for future osteoarthritis (OA) and degenerative joint disease progression. Despite multiple clinically available therapies that succeed in providing short term pain reduction and restoration of limited mobility, current treatments do not reliably regenerate native hyaline cartilage or halt cartilage degeneration at these defect sites. Novel therapeutics aimed at addressing limitations of current clinical cartilage regeneration therapies in…

  • Interferon-Gamma Primed Human Clonal Mesenchymal Stromal Cell Sheets Exhibit Enhanced Immunosuppressive Function

    Cells · 2022-11-23 · 29 citations

    articleOpen accessSenior authorCorresponding

    Mesenchymal stromal cells (MSCs) represent a promising treatment for immune-related diseases due to their diverse immunomodulatory paracrine functions. However, progress of culture-expanded MSCs is hindered by inconsistent cell function, poor localization, and insufficient retention when administered as suspended cell injections, thus placing spatiotemporal dosing constraints on therapeutic functions. To address these limitations, we introduce the combination of in vitro interferon-gamma (IFN-γ)…

  • Safety and efficacy of human juvenile chondrocyte-derived cell sheets for osteochondral defect treatment

    npj Regenerative Medicine · 2021 · 27 citations

    Senior authorCorresponding

    Knee cartilage does not regenerate spontaneously after injury, and a gold standard regenerative treatment algorithm has not been established. This study demonstrates preclinical safety and efficacy of scaffold-free, human juvenile cartilage-derived-chondrocyte (JCC) sheets produced from routine surgical discards using thermo-responsive cultureware. JCCs exhibit stable and high growth potential in vitro over passage 10, supporting possibilities for scale-up to mass production for commercializatio…

  • Polydactyly-derived allogeneic chondrocyte cell-sheet transplantation with high tibial osteotomy as regenerative therapy for knee osteoarthritis

    npj Regenerative Medicine · 2022-12-16 · 26 citations

    articleOpen access

    Allogeneic cell therapies are not fully effective in treating osteoarthritis of the knee (OAK). We recently reported that transplantation of autologous chondrocyte cell-sheets along with open-wedge high tibial osteotomy promoted hyaline cartilage repair in humans. Here we describe our regenerative therapy for OAK using polydactyly-derived allogeneic chondrocyte cell-sheets (PD sheets) and temperature-responsive culture inserts. Ten patients with OAK and cartilage defects categorized arthroscopic…

Frequent coauthors

  • Masayuki Yamato

    Tohoku University Hospital

    620 shared
  • Akihiko Kikuchi

    Social Insurance Saitama Chuo Hospital

    404 shared
  • Tatsuya Shimizu

    Tokyo Women's Medical University

    256 shared
  • Jun Kobayashi

    Josai University

    211 shared
  • Yoshikatsu Akiyama

    Tokyo Women's Medical University

    178 shared
  • Yasuhisa Sakurai

    Mitsui Memorial Hospital

    155 shared
  • Hideko Kanazawa

    Keio University

    147 shared
  • Kazunori Kataoka

    Johns Hopkins University

    144 shared

Education

  • Ph.D., Polymer Chemistry

    Waseda University

    1979
  • M.S., Polymer Chemistry

    Waseda University

    1976
  • B.S., Applied Chemistry

    Waseda University

    1974

Similar researchers at University of Utah

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Teruo Okano

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup